• Explore /
  • Poster
  • / Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS.

Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS.

Abstract Poster

Authors

null

Wasat Mansoor

Christie NHS, Manchester, United Kingdom

Wasat Mansoor , Hendrik-Tobias Arkenau , Maria Alsina , Kohei Shitara , Mohamedtaki Abdulaziz Tejani , Peter C. Thuss-Patience , Sinead Cuffe , Mikhail Dvorkin , David Park , Takayuki Ando , Marc Van Den Eynde , Giordano D. Beretta , Alberto Zaniboni , Toshihiko Doi , Josep Tabernero , David H. Ilson , Lukas Makris , Sandra McGuigan , Eric Van Cutsem

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02500043

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4038)

DOI

10.1200/JCO.2019.37.15_suppl.4038

Abstract #

4038

Poster Bd #

143

Abstract Disclosures

Similar Posters

First Author: Josep Tabernero

First Author: Maria Alsina

First Author: Kohei Shitara

First Author: Huiyan Luo